2025-05-21Niranjan Ghatule
IndusInd Bank reported a surprising net loss of ₹2,329 crore in Q4 FY25, marking its first quarterly loss in 20 years. The loss was primarily driven by a ₹2,000 crore hit in the derivatives segment and accounting lapses in the microfinance business.
View more
2025-05-13Niranjan Ghatule
Tata Motors delivered a strong performance in Q4 and FY25, posting record profits, becoming net debt-free, and maintaining positive free cash flow. Each segment—Jaguar Land Rover, Commercial Vehicles, and Passenger Vehicles—showed resilience, with management highlighting growth in profitability.
View more
2025-05-13Niranjan Ghatule
Gold prices have dropped 7.5% from their all-time high of $3,503 amid easing global tensions. Key reasons include reduced geopolitical stress between India-Pakistan, the US-China trade deal signed in Geneva, Trump's 90-day tariff pause and deal with the UK, and a ceasefire agreement in the Russia-Ukraine war
View more
2025-05-12Niranjan Ghatule
SRF Limited has reported a strong set of Q4FY25 results, marking a significant turnaround in its performance. The company’s net profit rose 25% year-on-year to ₹526 crore, doubling on a quarter-on-quarter basis. Revenue increased 21% YoY to ₹3,313 crore, while EBITDA grew 38% with improved margins of 22.2% compared to 19.5% last year.
View more
2025-05-08Niranjan Ghatule
Asian Paints' Q4 FY25 net profit drops 45% to Rs 700 crore despite exceptional gains. Revenue, EBITDA, and margins decline as competition from Birla Opus and JSW Paints intensifies. Full dividend details and share price update included.
View more
2025-05-08Niranjan Ghatule
In the wake of Operation Sindoor and the brutal terrorist attack in Pahalgam, countries across the world have voiced strong support for India. From powerful statements by global leaders to clear calls for action against terrorism, the international community has rallied behind India’s right to defend itself and dismantle terror networks.
View more
2025-05-07Niranjan Ghatule
Shares of Aarti Drugs surged 20% to hit the upper circuit at Rs 420 following strong Q4 FY24 results and favorable legal relief. The company reported a sharp rise in revenue and profit continues its Rs 600 crore capex-driven growth journey. With leadership in over 50 API molecules and a robust global footprint, Aarti Drugs is positioned for long-term expansion.
View more
2025-05-06Niranjan Ghatule
Polycab shares rise 9% in just two trading sessions, and today the company declared the March quarter results in which the Net profit rises by 33% YOY to Rs 726 crore, and revenue of company rises by 25% YOY
View more
2025-05-05Niranjan Ghatule
Shares of wire and cable manufacturing companies rise to 13% as on strong Q4 results of RR Kabel Limited and strong future guidance
View more
Your experience on this site will be improved by allowing cookies
Cookie Policy
